in its evaluation of the eswl for safety and effectiveness , the fda considered the question of alternative practices and procedures to treat nephrolithiasis , including percutaneous nephrolithotomy and open surgical procedures , and the adverse effects of such procedures .
C0184661
procedures
C0543467
surgical procedures